Revolutionizing Diabetes Care with CGM
The Continuous Glucose Monitoring (CGM) revolution is here! It's changing how we manage blood glucose levels.
A Shift in the Market
The industry is moving from high-volume consumables to high-value subscriptions.
- CGM revenues are surging, while BGM revenues decline in developed markets [1].
- This shift is driven by the benefits of CGM, including improved glucose control and reduced hypoglycemia.
Who's Adopting CGM?
- People with type 1 diabetes and insulin-intensive type 2 diabetes are ditching routine finger-sticks for CGMs [2].
- They're drawn to the superior data and expanding reimbursement options.
- BGM usage in these groups has dropped by up to 90% - it's now mainly used as a backup [3].
Where BGM Still Dominates
- BGM remains the top choice in non-insulin type 2 diabetes and emerging markets due to lower costs [4].
- Test strips are still essential for sensor calibration, verifying outliers, and covering sensor warm-up periods [5].
How Manufacturers Are Adapting
- Companies without CGM portfolios are pivoting to digital health solutions and emerging markets [6].
- Hybrid companies are navigating the transition from strips to sensors [7].